Department of Dermatology, Dokkyo Medical University, School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan.
Br J Dermatol. 2010 Oct;163(4):704-10. doi: 10.1111/j.1365-2133.2010.09874.x.
Vascular-type Ehlers-Danlos syndrome (vEDS) is a severe autosomal dominant inherited disorder resulting from mutations within the α1 type III collagen gene (COL3A1). The majority of published mutations are base changes leading to the substitution of single glycine residues within the triple-helical domain of type III collagen. Although clinical characteristics and mutations in the COL3A1 gene have been analysed for some patients from Europe and America, similar analyses have not yet been performed for Japanese patients with vEDS.
To analyse the genetic and phenotypic findings in Japanese patients with vEDS.
We analysed the clinical features of 20 unrelated individuals with vEDS. To quantify type III collagen production, the fibroblasts were cultured with (3) H-proline, and the radiolabelled collagenous proteins were analysed using sodium dodecyl sulphate-polyacrylamide gel electrophoresis and fluorography. Mutations in COL3A1 were detected by sequence analysis of cDNA from patients' fibroblasts and subsequently by a genomic DNA sequence analysis.
Thin and translucent skin with extensive bruising and hypermobility of the small joints were observed in about 90% of the patients, whereas the prevalence of serious clinical findings such as rupture/dissection/aneurysm of the arteries (30%) or rupture of the gastrointestinal tract (25%) was relatively low. Sequence analyses of the COL3A1 gene demonstrated heterozygous point mutations leading to glycine substitution in only nine patients (45%), while heterozygous splice-site mutations at the junction of the triple-helical exons were observed in the remaining 11 patients (55%). The average type III collagen production level in the cultured dermal fibroblasts was 14·6% of the normal value. The types of complication were not associated with specific mutations in COL3A1.
The analysis in the present series revealed a low frequency of patients presenting with serious clinical findings such as arterial rupture/arterial dissection/aneurysm and perforation or rupture of the gastrointestinal tract, and revealed a higher prevalence of splice-site mutations at the junction of the triple-helical exons than of glycine substitution mutations in COL3A1.
血管型埃勒斯-当洛斯综合征(vEDS)是一种严重的常染色体显性遗传性疾病,由 α1 型 III 型胶原蛋白基因(COL3A1)中的突变引起。大多数已发表的突变是碱基变化,导致 III 型胶原蛋白三螺旋结构域中单个甘氨酸残基的取代。尽管已经分析了来自欧美一些患者的 COL3A1 基因突变和临床特征,但尚未对日本 vEDS 患者进行类似的分析。
分析日本 vEDS 患者的遗传和表型发现。
我们分析了 20 名无关的 vEDS 患者的临床特征。为了定量测定 III 型胶原蛋白的产生,将成纤维细胞用(3)H-脯氨酸培养,并通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳和荧光法分析放射性标记的胶原蛋白。通过对患者成纤维细胞的 cDNA 进行序列分析,随后对基因组 DNA 序列分析,检测 COL3A1 中的突变。
约 90%的患者皮肤薄而半透明,易瘀伤,小关节活动过度,而严重的临床发现,如动脉破裂/夹层/动脉瘤(30%)或胃肠道破裂(25%)的患病率相对较低。COL3A1 基因的序列分析仅在 9 名患者(45%)中发现导致甘氨酸取代的杂合点突变,而在其余 11 名患者(55%)中观察到三螺旋外显子交界处的杂合剪接位点突变。培养的真皮成纤维细胞中 III 型胶原蛋白的产生水平平均为正常值的 14.6%。并发症的类型与 COL3A1 中的特定突变无关。
本系列分析显示,出现严重临床发现(如动脉破裂/动脉夹层/动脉瘤和胃肠道穿孔或破裂)的患者频率较低,且 COL3A1 中存在剪接位点突变的患者比例高于甘氨酸取代突变。